IDEAYA Biosciences Appoints New CMO, Elects Directors
Ticker: IDYA · Form: 8-K · Filed: Jun 27, 2024 · CIK: 1676725
| Field | Detail |
|---|---|
| Company | Ideaya Biosciences, Inc. (IDYA) |
| Form Type | 8-K |
| Filed Date | Jun 27, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, board-election, compensation
TL;DR
IDEAYA adds new CMO & board members, stock options granted.
AI Summary
IDEAYA Biosciences, Inc. announced on June 21, 2024, the appointment of Dr. S. Mark Albagli as Chief Medical Officer and the election of Dr. Albagli and Ms. Sarah E. Kelly to its Board of Directors. The company also disclosed compensatory arrangements for certain officers, including stock options and restricted stock units, as part of its ongoing business operations.
Why It Matters
The appointment of a new Chief Medical Officer and board members can signal strategic shifts in the company's leadership and direction, potentially impacting its drug development pipeline and future growth.
Risk Assessment
Risk Level: medium — Changes in key leadership and board composition can introduce uncertainty, while compensatory arrangements may impact future dilution.
Key Players & Entities
- IDEAYA Biosciences, Inc. (company) — Registrant
- Dr. S. Mark Albagli (person) — Appointed Chief Medical Officer and elected to Board of Directors
- Ms. Sarah E. Kelly (person) — Elected to Board of Directors
- June 21, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer?
Dr. S. Mark Albagli has been appointed as the new Chief Medical Officer.
Who has been elected to IDEAYA Biosciences' Board of Directors?
Dr. S. Mark Albagli and Ms. Sarah E. Kelly have been elected to the Board of Directors.
What is the date of the earliest event reported in this 8-K filing?
The date of the earliest event reported is June 21, 2024.
What are the key items reported in this 8-K filing?
The key items reported are the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers.
What is the state of incorporation for IDEAYA Biosciences, Inc.?
IDEAYA Biosciences, Inc. is incorporated in Delaware.
Filing Stats: 422 words · 2 min read · ~1 pages · Grade level 12.5 · Accepted 2024-06-27 06:06:32
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share IDYA The Nasdaq
Filing Documents
- d836119d8k.htm (8-K) — 21KB
- 0001193125-24-169573.txt ( ) — 140KB
- idya-20240621.xsd (EX-101.SCH) — 3KB
- idya-20240621_lab.xml (EX-101.LAB) — 18KB
- idya-20240621_pre.xml (EX-101.PRE) — 11KB
- d836119d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IDEAYA BIOSCIENCES, INC. Date: June 27, 2024 By: /s/ Yujiro Hata Yujiro Hata President and Chief Executive Officer